Studies revealed that breast cancer cell differentiation is regulated by the MT-1 signaling pathway [28, 29], while the anticancer function of melatonin is mediated by MT-1 receptor and G protein-coupled signal transduction in liver cancer cells [30]. Here, MTNR1A is linked to breast cancer.